Naratriptan and Chest pain - a phase IV clinical study of FDA data

Summary:

Chest pain is reported as a side effect among people who take Naratriptan (naratriptan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lyrica, and have Indigestion.

The phase IV clinical study analyzes which people have Chest pain when taking Naratriptan. It is created by eHealthMe based on reports of 1,407 people who have side effects when taking Naratriptan from the FDA, and is updated regularly.

What is Naratriptan?

Naratriptan has active ingredients of naratriptan. It is often used in migraine. eHealthMe is studying from 1,481 Naratriptan users. Check the latest studies of Naratriptan.

What is Chest pain?

Chest pain is found to be associated with 3,471 drugs and 4,888 conditions by eHealthMe. Check the latest studies of Chest pain.

On Jul, 05, 2026

1,407 people reported to have side effects when taking Naratriptan.
Among them, 34 people (2.42%) have Chest pain.

Among these 34 people:

How long have people been on Naratriptan when they have Chest pain? *

What is the gender of people who have Chest pain when taking Naratriptan? *

female: 67.74 %
male: 32.26 %

What is the age of people who have Chest pain when taking Naratriptan? *

What are other drugs people take besides Naratriptan? *

What are other side effects people have besides Chest pain? *

Dizziness: 8 people, 23.53%
Abdominal Pain: 8 people, 23.53%
Drug Ineffective: 7 people, 20.59%
Stress And Anxiety: 5 people, 14.71%
Dyspnea (difficult or laboured breathing): 5 people, 14.71%
Abdominal Distension: 5 people, 14.71%
Back Pain: 5 people, 14.71%
Abdominal Pain Upper: 5 people, 14.71%
Urine Flow Decreased: 4 people, 11.76%
Nausea And Vomiting: 4 people, 11.76%

What are the existing conditions these people have? *

Indigestion: 7 people, 20.59%
Headache (pain in head): 4 people, 11.76%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 4 people, 11.76%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 8.82%
Pain In Extremity: 3 people, 8.82%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 8.82%
Herpes Zoster: 2 people, 5.88%
Stress And Anxiety: 2 people, 5.88%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 5.88%
Migraine Without Aura (headache without neurological problems): 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Naratriptan and have Chest pain?

- Check whether Chest pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Naratriptan:

Naratriptan (1,481 reports)

Chest pain treatments and more:

Chest pain (363,501 reports)

Browse all side effects of Naratriptan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest pain:

Chest pain (3,471 drugs)

Browse all the conditions that are associated with Chest pain:

Chest pain (4,888 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on naratriptan (the active ingredients of Naratriptan) and Naratriptan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.